Citadel Advisors - VOLITIONRX LTD ownership

VOLITIONRX LTD's ticker is VNRX and the CUSIP is 928661107. A total of 36 filers reported holding VOLITIONRX LTD in Q3 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of VOLITIONRX LTD
ValueSharesWeighting
Q2 2023$39,222
-65.2%
28,217
-52.2%
0.00%
Q1 2023$112,724
-62.5%
59,018
-52.3%
0.00%
Q4 2022$300,725
+55.0%
123,755
-13.5%
0.00%
Q3 2022$194,000
+43.7%
143,077
+116.9%
0.00%
Q2 2022$135,000
-25.8%
65,976
+9.3%
0.00%
Q1 2022$182,000
+2.8%
60,338
+6.5%
0.00%
Q4 2021$177,000
+3.5%
56,638
+2.5%
0.00%
Q3 2021$171,000
+185.0%
55,275
+205.4%
0.00%
Q2 2021$60,000
+20.0%
18,100
+40.6%
0.00%
Q2 2020$50,00012,8750.00%
Other shareholders
VOLITIONRX LTD shareholders Q3 2022
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 1,901,467$6,180,0007.86%
Leisure Capital Management 69,337$225,0000.19%
GARRISON BRADFORD & ASSOCIATES INC 15,500$50,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 224,400$729,0000.01%
Hartford Financial Management Inc. 8,300$27,0000.01%
OPPENHEIMER & CO INC 38,144$124,0000.00%
BlueCrest Capital Management Ltd 24,772$81,0000.00%
BREWIN DOLPHIN LTD 6,575$21,3690.00%
Virtu Financial LLC 10,794$35,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 22,500$74,0000.00%
View complete list of VOLITIONRX LTD shareholders